PTH and hypoparathyroidism: This current analysis extends the primary findings of the REPLACE study and provides further mechanistic evidence that therapy with rhPTH(1–84), in contrast to conventional therapy with oral calcium and active vitamin D, mimics the action of endogenous PTH in patients with hypoparathyroidism [12].